Assertio Holdings (ASRT) Assets Average (2020 - 2026)
Assertio Holdings' (ASRT) quarterly Assets Average came in at $239.1 million in Q1 2026, down 16.26% year-on-year from $285.6 million in Q1 2025, and down 18.49% quarter-over-quarter from $293.4 million in Q4 2025.
Assertio Holdings (ASRT) Assets Average (2020 - 2026) Analysis & Trends
Assertio Holdings has disclosed Assets Average across 7 years of filings, most recently posting $239.1 million for Q1 2026.
- Assets Average for Q1 2026 came in at $239.1 million, down 16.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $239.1 million (down 16.26% YoY), and the FY2025 annual result was $275.9 million, down 3.41% from the prior year.
- Assets Average came in at $239.1 million for Q1 2026 at Assertio Holdings, down from $293.4 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $414.1 million in Q1 2023 to a low of $239.1 million in Q1 2026.
- The 5-year median for Assets Average is $296.8 million (2025), against an average of $319.0 million.
- Across the five-year window, Assets Average gained 24.41% in 2023 and plunged 31.49% in 2024, its largest moves.
- Assertio Holdings' Assets Average stood at $368.6 million in 2022, then dropped by 9.6% to $333.2 million in 2023, then slipped by 15.86% to $280.4 million in 2024, then advanced by 4.64% to $293.4 million in 2025, then fell by 18.49% to $239.1 million in 2026.
- The last three Assets Average figures came in at $239.1 million (Q1 2026), $293.4 million (Q4 2025), and $296.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.21 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.29 Bn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | 239.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 239.13 Mn |
| Dec 31, 2025 | 293.37 Mn |
| Sep 30, 2025 | 296.78 Mn |
| Jun 30, 2025 | 280.10 Mn |
| Mar 31, 2025 | 285.58 Mn |
| Dec 31, 2024 | 280.37 Mn |
| Sep 30, 2024 | 277.72 Mn |
| Jun 30, 2024 | 280.70 Mn |
| Mar 31, 2024 | 284.19 Mn |
| Dec 31, 2023 | 333.22 Mn |
| Sep 30, 2023 | 392.60 Mn |
| Jun 30, 2023 | 409.73 Mn |
| Mar 31, 2023 | 414.09 Mn |
| Dec 31, 2022 | 368.63 Mn |
| Sep 30, 2022 | 322.66 Mn |
| Jun 30, 2022 | 330.56 Mn |
| Mar 31, 2022 | 332.84 Mn |
| Dec 31, 2021 | 312.93 Mn |
| Sep 30, 2021 | 305.66 Mn |
| Jun 30, 2021 | 318.72 Mn |